欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/V/0137/001
药品名称BioBos IBR marker live
活性成分
    • bovine herpesvirus 10.57 TCID50/dose
剂型Lyophilisate and solvent for suspension for injection
上市许可持有人Bioveta, a.s. Komenskeho 212 683 23 Ivanovice na Hane Czech Republic
参考成员国 - 产品名称Czechia (CZ)
BioBos IBR marker live, lyofilizát a rozpouštědlo pro suspenzi
互认成员国 - 产品名称
    • Greece (GR)
    • Latvia (LV)
    • Estonia (EE)
      BioBos IBR marker live
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
    • Romania (RO)
许可日期2017/03/29
最近更新日期2024/11/19
药物ATC编码
    • QI02AD01 bovine rhinotracheitis virus (IBR)
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase